Griffon Boost FY24 Revenue Outlook - Update

While reporting financial results for the second quarter on Wednesday, Griffon Corp. (GFF) raised its revenue expectation for the full-year 2024 to $2.65 billion from the prior guidance of $2.6 billion. On average, five analysts polled by Thomson Reuters expect the company to report revenues of $2.63 billion for the year. Separately, the Board of...

Read More

Bay Street Seen Opening On Mixed Note

Canadian shares are likely to turn in a mixed performance on Wednesday with investors reacting to quarterly earnings updates. Weak crude oil prices and subdued bullion market may weigh on energy and materials shares. In earnings news, Stella-Jones Inc (SJ.TO) reported a net income of $77 million or $1.36 per share for the first quarter...

Read More

Anixa Inks Joint Development Agreement With Cleveland Clinic To Develop Novel Cancer Vaccines

Biotechnology company Anixa Biosciences, Inc. (ANIX) announced Wednesday that it has entered into a joint development agreement with Cleveland Clinic to develop novel vaccines for various cancer types. Anixa currently collaborates with Cleveland Clinic on breast cancer and ovarian cancer vaccines Cleveland Clinic is currently conducting a Phase 1 clinical trial targeting triple negative breast...

Read More

CAC 40 Inches Higher After Trade Data

French stocks were slightly higher on Tuesday after data from the customs offices showed France\'s trade deficit decreased in March. The trade deficit dropped to EUR 5.47 billion in March from EUR 5.61 billion in February as exports rose faster than imports. In the same period last year, the deficit totaled EUR 8.1 billion. Exports...

Read More